NFKB1 and cardiovascular disorder: This, and given the fact that the targeting of NF-κB by auraptene is elucidated to ameliorate diverse pathophysiological conditions, more pre-clinical research might also bestow upon platelet NF-κB a therapeutic potential in cardiovascular diseases.